Isabel Cochrane

Isabel Cochrane is a Global Brand Manager at Merz Therapeutics, responsible for managing the global brand strategy for XEOMIN (incobotulinumtoxinA), focusing on brand identity, visibility through marketing campaigns, and stakeholder relationships. Prior experience includes serving as Marketing Manager for the CURIA app at Innoplexus, where Isabel led successful market launches and increased user engagement. Isabel began a career in marketing communications at Edelman, advancing from Assistant Account Executive to Senior Account Executive, managing international pharma campaigns. Educational qualifications include a Bachelor's Degree in International Management and German from the University of Bath and A levels in Business, German Studies, Philosophy and Ethics, and Psychology from Derby High School.